Answers are grounded in this paper and cite their sources.
Purpose: Gleason pattern 4 (GP4) in prostate biopsy (PB) samples has been linked to adverse pathology during radical prostatectomy (RP). This study investigated the role of the total GP4 length in predicting pT3 disease and adverse oncological outcomes after surgery. Methods: A retrospective analysis was conducted on 2600 PB cores from 187 patients with grade group 2 to 4 prostate cancer and PSA ≤ 20 ng/mL who underwent RP. The total GP4 length, defined as the cumulative length of GP4 across all PB cores per individual, was evaluated along with the clinical and biopsy characteristics. Logistic regression models were used to assess the predictors of pT3 disease. ROC curve analysis was used to evaluate diagnostic performance. Results: Of the cohort, 82 (43.9%) had pT2 disease and 105 (56.1%) had pT3 disease. The median total GP4 length was significantly higher in pT3 disease (17.8 mm; IQR 3.5-25.6) than pT2 disease (3.96 mm; IQR 0.5-5.7) P = .001. Total GP4 length was a strong predictor of pT3 disease in univariate (odds ratio [OR] 4.12, 95% confidence interval [CI] 2.2-7.6, P = .0001) and multivariate (OR 4.5, 95% CI 1.9-10.6, P = .001) analyses. ROC analysis demonstrated robust predictive accuracy (AUC = 0.79, 95% CI 0.7-0.8, P = .0001). Conclusions: The total GP4 length in PB samples outperformed traditional prognostic markers in predicting pT3 disease. Incorporating GP4 measurements into pathology reports may enhance treatment decisions. Further prospective studies are required to validate our findings.
No takes yet. Share an insight, caveat, or question.
Sandoval et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: